[Helicobacter pylori infection and gastric MALT lymphoma: present-day approaches to research and treatment]

MeSH terms

• Antineoplastic Agents, Alkylating / therapeutic use
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Chlorambucil / therapeutic use
• Chromosome Aberrations
• Chronic Disease
• Combined Modality Therapy
• Cyclophosphamide / therapeutic use
• Doxorubicin / therapeutic use
• Gastritis / complications
• Gastritis / etiology
• Helicobacter Infections / complications*
• Helicobacter Infections / drug therapy
• Helicobacter pylori*
• Humans
• Lymphoma, B-Cell, Marginal Zone / diagnosis
• Lymphoma, B-Cell, Marginal Zone / drug therapy
• Lymphoma, B-Cell, Marginal Zone / etiology*
• Lymphoma, B-Cell, Marginal Zone / genetics
• Lymphoma, B-Cell, Marginal Zone / pathology
• Lymphoma, B-Cell, Marginal Zone / surgery
• Molecular Biology
• Multicenter Studies as Topic
• Mutation
• Phenotype
• Prednisone / therapeutic use
• Prognosis
• Randomized Controlled Trials as Topic
• Research
• Stomach / pathology
• Stomach Neoplasms / diagnosis
• Stomach Neoplasms / drug therapy
• Stomach Neoplasms / etiology*
• Stomach Neoplasms / pathology
• Stomach Neoplasms / surgery
• Vincristine / therapeutic use